We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQBK icon
3551
Equity Bancshares
EQBK
$1.07B
$25K ﹤0.01%
853
+619
+265% +$19.4K
ETD icon
3552
Ethan Allen Interiors
ETD
$583M
$25K ﹤0.01%
1,230
+952
+342% +$22.5K
LKFT
3553
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$25K ﹤0.01%
457
-2,058
-82% -$122K
GOSS icon
3554
Gossamer Bio
GOSS
$83.3M
$25K ﹤0.01%
2,936
-5,315
-64% -$41.2K
HIMS icon
3555
Hims & Hers Health
HIMS
$6.71B
$25K ﹤0.01%
+5,605
New +$23.9K
HUYA
3556
Huya Inc
HUYA
$538M
$25K ﹤0.01%
6,420
-21,455
-77% -$89.6K
IMNN icon
3557
Imunon
IMNN
$6.64M
$25K ﹤0.01%
1,019
+626
+159% +$22.9K
IRMD icon
3558
iRadimed
IRMD
$1.11B
$25K ﹤0.01%
747
-615
-45% -$22K
IWS icon
3559
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
$25K ﹤0.01%
248
+187
+307% +$20.9K
KREF
3560
KKR Real Estate Finance Trust
KREF
$502M
$25K ﹤0.01%
1,422
+1,024
+257% +$19.7K
LOB icon
3561
Live Oak Bancshares
LOB
$2.01B
$25K ﹤0.01%
750
+615
+456% +$25.4K
MCFT icon
3562
MasterCraft Boat Holdings
MCFT
$598M
$25K ﹤0.01%
1,192
+697
+141% +$16.2K
MCRB icon
3563
Seres Therapeutics
MCRB
$45M
$25K ﹤0.01%
369
-483
-57% -$41.6K
MRUS
3564
DELISTED
Merus
MRUS
$25K ﹤0.01%
1,091
-2,250
-67% -$47K
MVIS icon
3565
Microvision
MVIS
$89.7M
$25K ﹤0.01%
434
-494
-53% -$26.5K
MYE icon
3566
Myers Industries
MYE
$1.25B
$25K ﹤0.01%
1,078
-6,789
-86% -$154K
NUTX
3567
Nutex Health
NUTX
$1.28B
$25K ﹤0.01%
+51
New +$60.1K
OFS icon
3568
OFS Capital
OFS
$48.2M
$25K ﹤0.01%
+2,489
New +$30.1K
PLRX icon
3569
Pliant Therapeutics
PLRX
$66.9M
$25K ﹤0.01%
3,123
+853
+38% +$5.46K
POWL icon
3570
Powell Industries
POWL
$7.43B
$25K ﹤0.01%
3,207
-12,663
-80% -$99K
PPIH
3571
Perma-Pipe International
PPIH
$216M
$25K ﹤0.01%
2,801
+2,202
+368% +$24.6K
REI icon
3572
Ring Energy
REI
$349M
$25K ﹤0.01%
9,073
-11,175
-55% -$46.3K
RYTM icon
3573
Rhythm Pharmaceuticals
RYTM
$7.99B
$25K ﹤0.01%
5,804
-28,704
-83% -$157K
SVRA icon
3574
Savara
SVRA
$1.08B
$25K ﹤0.01%
+16,157
New +$21.2K
UIS icon
3575
Unisys
UIS
$210M
$25K ﹤0.01%
2,080
+1,177
+130% +$16.6K
141 142
143
144 145

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.